Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Chemo-elimination (TCE) to Eradicate Malaria in Areas of Suspected or Proven Artemisinin Resistance in Southeast Asia and South Asia

NCT01872702 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT01872702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01872702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Chemo-elimination (TCE) to Eradicate Malaria in Areas of Suspected or Proven Artemisinin Resistance in Southeast Asia and South Asia
Lead sponsor
University of Oxford
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
July 31, 2017
Enrollment
8,000 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium falciparum malaria